Results
|
|
861.
|
|
|
|
862.
|
|
|
|
863.
|
|
|
|
864.
|
|
|
|
865.
|
|
|
|
866.
|
|
|
|
867.
|
Antisense-mediated reduction of proprotein convertase subtilisin/kexin type 9 (PCSK9): a first-in-human randomized, placebo-controlled trial. [electronic resource] by
- van Poelgeest, Eveline P
- Hodges, Michael R
- Moerland, Matthijs
- Tessier, Yann
- Levin, Arthur A
- Persson, Robert
- Lindholm, Marie W
- Dumong Erichsen, Kamille
- Ørum, Henrik
- Cohen, Adam F
- Burggraaf, Jacobus
Producer: 20160929
In:
British journal of clinical pharmacology vol. 80
Availability: No items available.
|
|
|
868.
|
|
|
|
869.
|
|
|
|
870.
|
Role of PCSK9 in the course of ejection fraction change after ST-segment elevation myocardial infarction: a pilot study. [electronic resource] by
- Miñana, Gema
- Núñez, Julio
- Bayés-Genís, Antoni
- Revuelta-López, Elena
- Ríos-Navarro, César
- Núñez, Eduardo
- Chorro, Francisco J
- López-Lereu, Maria Pilar
- Monmeneu, Jose Vicente
- Lupón, Josep
- Sanchis, Juan
- Bodí, Vicent
Producer: 20210526
In:
ESC heart failure vol. 7
Availability: No items available.
|
|
|
871.
|
|
|
|
872.
|
|
|
|
873.
|
|
|
|
874.
|
Combined administration of RG7652, a recombinant human monoclonal antibody against PCSK9, and atorvastatin does not result in reduction of immune function. [electronic resource] by
- Gelzleichter, Thomas R
- Halpern, Wendy
- Erwin, Roy
- Baruch, Amos
- Leabman, Maya
- Forrest, Abigail S
- Satterwhite, Christina M
- Peng, Kun
- Chilton, Jennifer
- Stevens, Dale
Producer: 20150330
In:
Toxicological sciences : an official journal of the Society of Toxicology vol. 140
Availability: No items available.
|
|
|
875.
|
|
|
|
876.
|
|
|
|
877.
|
|
|
|
878.
|
Evaluation of PCSK9 levels and its genetic polymorphisms in women with polycystic ovary syndrome. [electronic resource] by
- Xavier, Luana B
- Sóter, Mirelle O
- Sales, Mariana F
- Oliveira, Daisy K
- Reis, Helton J
- Candido, Ana L
- Reis, Fernando M
- Silva, Ieda O
- Gomes, Karina B
- Ferreira, Cláudia N
Producer: 20180119
In:
Gene vol. 644
Availability: No items available.
|
|
|
879.
|
|
|
|
880.
|
PCSK9 inhibition-mediated reduction in Lp(a) with evolocumab: an analysis of 10 clinical trials and the LDL receptor's role. [electronic resource] by
- Raal, Frederick J
- Giugliano, Robert P
- Sabatine, Marc S
- Koren, Michael J
- Blom, Dirk
- Seidah, Nabil G
- Honarpour, Narimon
- Lira, Armando
- Xue, Allen
- Chiruvolu, Padmaja
- Jackson, Simon
- Di, Mei
- Peach, Matthew
- Somaratne, Ransi
- Wasserman, Scott M
- Scott, Rob
- Stein, Evan A
Producer: 20170825
In:
Journal of lipid research vol. 57
Availability: No items available.
|